A detailed history of Omnia Family Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Omnia Family Wealth, LLC holds 1,998 shares of LLY stock, worth $1.56 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
1,998
Previous 1,893 5.55%
Holding current value
$1.56 Million
Previous $1.71 Million 3.33%
% of portfolio
0.76%
Previous 0.73%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$772.14 - $960.02 $81,074 - $100,802
105 Added 5.55%
1,998 $1.77 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $31,894 - $39,997
44 Added 2.38%
1,893 $1.71 Million
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $25,464 - $34,068
43 Added 2.38%
1,849 $1.44 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $7,352 - $8,667
14 Added 0.78%
1,806 $1.05 Million
Q3 2023

Nov 01, 2023

BUY
$434.7 - $599.3 $5,216 - $7,191
12 Added 0.67%
1,792 $962,000
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $3,507 - $4,689
10 Added 0.56%
1,780 $834,000
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $7,765 - $9,120
25 Added 1.43%
1,770 $607,000
Q1 2022

May 06, 2022

BUY
$234.69 - $291.66 $5,867 - $7,291
25 Added 1.45%
1,745 $500,000
Q4 2019

Feb 05, 2020

BUY
$106.92 - $132.43 $183,902 - $227,779
1,720 New
1,720 $226,000
Q2 2019

Aug 07, 2019

SELL
$110.79 - $129.32 $190,558 - $222,430
-1,720 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $122,997 - $144,777
-1,105 Reduced 39.12%
1,720 $223,000
Q4 2018

Feb 26, 2019

SELL
$105.9 - $118.64 $36,535 - $40,930
-345 Reduced 10.88%
2,825 $327,000
Q4 2017

Feb 02, 2018

BUY
$81.94 - $87.89 $737 - $791
9 Added 0.28%
3,170 $268,000
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $7,861 - $8,725
-102 Reduced 3.13%
3,161 $270,000
Q2 2017

Aug 10, 2017

BUY
N/A
3,263
3,263 $269,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Omnia Family Wealth, LLC Portfolio

Follow Omnia Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omnia Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omnia Family Wealth, LLC with notifications on news.